Sign in

CIK 0001022899

  • Non-accelerated filer
  • Smaller reporting company

Protagenic Therapeutics, Inc.new

Sign in to watch
Ticker
PTIX
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
061390025
Phone
+1 212-994-8200
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
  1. 4 Grant or award Director acquired 11,392 shares (grant or award)
  2. 4 Grant or award Director acquired 3,892 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 3,892 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award Director acquired 3,892 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy 10% owner bought 25,000 shares at $1.17 ($29,290)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy 10% owner bought 25,000 shares at $4.03 ($100,655)
  13. 4 Other acquisition President acquired 443,085 shares (other)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy 10% owner bought 10,000 shares at $4.30 ($42,968)
  18. 4 Open-market buy 10% owner bought 20,000 shares at an average $4.34 ($86,708)
  19. 4 Open-market buy 10% owner bought 10,000 shares at $4.21 ($42,071)
  20. 4 Open-market buy 10% owner bought 70,000 shares at an average $4.28 ($299,751)

Page 5 of 7 · 137 filings